“…A third translocation, t(11;14)(q13;q32), has been described in a wider spectrum of diseases and involves a putative oncogene, BCLl, which maps to chromosome band llq13 (Tsujimoto et al, 1984(Tsujimoto et al, , 1986Kluin and Van Krieken, 1991). The translocation has been reported in diffuse small-and large-cell lymphomas, multiple myeloma, and plasma cell leukemias (Dewald et al, 1985;Selvanayagam et al, 1987;Gould et al, 1988Ince et al, 1988Koduru et al, 1989Rodriguez et al, 1989Athan et al, 1991). More recently, there is evidence that this abnormality may delineate particular subtypes of non-Hodgkin lymphoma (NHL), such as intermediate lymphocytic and centrocytic (Medeiros et al, 1990;Rimokh et al, 1990;Wotherspoon et al, 1990;Frizzera et al, 1991;Leroux et al, 1991;Williams et al, 1990), designations that encompass mantle-cell-derived lymphomas (Raffeld and Jaffe, 1991).…”